Oncimmune Holdings plc (LON:ONC – Get Free Report) passed below its 50 day moving average during trading on Friday . The stock has a 50 day moving average of GBX 14.40 ($0.18) and traded as low as GBX 11.80 ($0.15). Oncimmune shares last traded at GBX 11.80 ($0.15), with a volume of 98,621 shares traded.
Oncimmune Trading Down 5.6 %
The firm has a market capitalization of £8.75 million, a price-to-earnings ratio of -393.33 and a beta of 1.19. The company has a quick ratio of 0.63, a current ratio of 1.13 and a debt-to-equity ratio of 806.85. The firm’s 50 day moving average is GBX 14.40 and its 200 day moving average is GBX 14.80.
About Oncimmune
Oncimmune Holdings plc, an immunodiagnostics company, develops solutions for immuno-oncology, autoimmune disease and infectious diseases in the United Kingdom, North America, Europe, and internationally. It offers EarlyCDT-Lung, an immunodiagnostic blood test for detecting and identifying lung cancer; ImmunoINSIGHTS that enables life science organizations to optimize drug development and delivery; SeroTag discovery arrays for discovering and validating biomarkers for stratifying patients in multiple cancer indications, infectious diseases, and with various autoimmune diseases; and NavigAID, a disease-specific characterization panel.
See Also
- Five stocks we like better than Oncimmune
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- Why Energy Transfer Stock Could Soar to New Highs in 2025
- Overbought Stocks Explained: Should You Trade Them?
- 3 Buy-and-Hold Stocks for Long-Term Growth
- Insider Trades May Not Tell You What You Think
- Despite Short-Term Risks Freeport McMoran Worth a Look
Receive News & Ratings for Oncimmune Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oncimmune and related companies with MarketBeat.com's FREE daily email newsletter.
